Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

There's a good chance that the going will get tougher.

Where Will Teladoc Be in 3 Years?

Caesars Entertainment

DraftKings

Robinhood

Hudson Pacific Properties

Penn Entertainment

SL Green Realty

Simon Property Group

24/7 Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new ideas for investors and traders alike.

8 Hot Stocks to Buy That Analysts Loved This Week

Cricut

DoorDash

Netflix

Nautilus

Pinterest

Zoom Video

As the delta variant drives a rapid increase in Covid-19 cases, consider these stocks to buy for another potential round of restrictions. The post 7 Coronavirus Stocks to Buy in Case of Lockdown 2.0 appeared first on InvestorPlace.

7 Coronavirus Stocks to Buy in Case of Lockdown 2.0

Fastly

Following a severe beating for all three stocks, their share prices seem to be getting some support.

Why Fastly, Pinterest, and Teladoc Health Stocks Notched Higher on Friday

American Well Corporation

Doximity

Every analyst's target is higher than the current price.

Wall Street Thinks You Can't Lose With This Healthcare Stock

Teladoc is growing at a lightning fast pace and needs to be valued like a company firing on all cylinders. The company has been growing at a rapid clip and continues to execute on its business model.

Teladoc Health: Lightning Growth At A Discount

Twilio

Unity Software

The cloud is reshaping the global economy and creating new business leaders.

3 Top Cloud Computing Stocks to Buy in August

Coinbase

Palantir Technologies

Roblox

Cathie Wood, the founder Chief Executive Officer of the Ark Invest financial management firm, follows an investment philosophy that is focused on disruptive and cutting edge technologies. It's a strategy that worked great in 2020, with Ark Invest's flagship ARK Innovation ETF returning 148% during last year.

4 Stocks to Buy If You Want to Follow Cathie Wood in August

SoFi Technologies

Clover Health Investments

Markets are under pressure, and that leaves the door open for short-term opportunities. That said, here are our top stock trades for Tuesday.

4 Top Stock Trades for Tuesday: FSLY, SOFI, TDOC, CLOV

Lemonade

Shares of these three companies have been slammed this year.

Why Fastly, Teladoc, and Lemonade Stocks Dipped on Monday

C3.ai

GameStop

Pubmatic

The initial trade that started the meme stock phenomena in earnest was on GameStop Corp.

Why These 5 Incredible Stocks Could Be the Next Meme Stock Winners

Upstart Holdings

These young upstarts have the potential to deliver 1,000% gains -- or more.

3 Top Growth Stocks That Could Be the Next 10-Baggers

Mastercard

The "people's currency" could be left in the dust by these fast-growing companies.

3 Growth Stocks That Can Run Circles Around Dogecoin

Many investors are skeptical about the future growth potential of the king of telehealth.

Is It Too Late to Buy Teladoc Health Stock?

The virtual-care leader's fortunes could be linked to what happens next with COVID-19 -- at least, for now.

Why Teladoc Stock Could Soar If Moderna's Scary Prediction Comes True

Novavax

Short-term pain in these innovators means long-term opportunity for investors.

Like Discounts? These 5 Game-Changing Stocks Are 35% (or More) Below Their 52-Week Highs

Michael Gorton's Recuro Health sees a bright future in home testing for blood sugar, heart health and more.

Teladoc Founder's Startup Brings Patient Monitoring Home

This stock looks like a great one to buy sooner rather than later.

3 Reasons to Buy Teladoc Health Stock in August

Teladoc's Earnings Had 1 Important Metric for Both Bulls and Bears

Root

Trupanion

Innovation and time could allow a sizable investment in this trio to turn into a life-altering amount of money.

3 Special Stocks That Can Turn $25,000 Into $1 Million in 25 Years (or Less)

Talkspace

They're making inroads on delivering behavioral health from afar.

2 Telehealth Companies Worth Adding to Your Watchlist

Heavy losses in its second-quarter earnings report contributed to the sell-off.

Why Teladoc Stock Fell 11% in July

Lufax Holding

Travelers

Picking stocks whose market capitalizations surpass $10 billion and whose price-book ratios are not above 1.5 could grant value investors a higher likelihood to unearth opportunities among U.S.-listed equities.

3 Low Price-Book Ratio Stock Picks

Exact Sciences

MercadoLibre

Roku

Shopify

Block

Tesla

Zillow

Trimble

The haters have come out against portfolio manager Cathie Wood. In fact, an ETF is preparing to launch that bets against her stocks to buy.

10 Stocks to Buy From Cathie Wood's Fleet of ETFs

Ciena

CyberArk Software

Datadog

Electronic Arts

Fiverr

Constellation Brands

Investors should be more selective in uncertain times. These coronavirus stocks are fundamentally strong enough to rebound after another potential pullback.

7 Coronavirus Stocks to Buy as the Delta Variant Rises

News for Teladoc Stock (TDOC)